Global Health will hold a meeting with investors and analysts on June 11, 2026, to discuss business developments. The interaction is organized by Emkay Investment Managers Limited and will provide stakeholders with an opportunity to engage directly with the company's leadership.

The meeting is scheduled to take place in Gurugram and will be conducted in person. The format is designated as a one-on-one session, allowing for focused dialogue between the management and individual investors or analysts.

The company clarified that no unpublished price sensitive information will be shared during the meeting. This disclosure aligns with the requirements of Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Rahul Ranjan, Company Secretary & Compliance Officer, signed the intimation on June 8, 2026. The meeting schedule remains subject to change in case of unforeseen circumstances involving the analysts, investors, or the company.

Global Health Limited management will engage with institutional investors during meetings scheduled in Singapore on June 09 and June 10, 2026. The interaction is part of the Kotak Institutional Equity India Corporate Day - Singapore 2026. The company confirmed that no unpublished price sensitive information will be shared during the event.

The disclosure was made to the stock exchanges pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meetings will be conducted in person, featuring both one-to-one and group discussions with investors.

Rahul Ranjan, Company Secretary & Compliance Officer, signed the intimation on behalf of Global Health Limited. The company noted that the schedule is subject to change in case of unforeseen circumstances involving analysts, investors, or the company.